Tukar Capital
Funding rounds backed by Tukar Capital.
- Funding disclosed in full
- $55M
- Median round
- $55M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Drug Farm Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases | $55MSeries D | BiotechChina | 12 participantsBiometasBioVeda China Fund (BVCF)Detong CapitalFuzhou Xinhe FundJiashan State VCKeyuan PharmaShanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity Fund Partnership EnterpriseShenzhen Luohu Donghai Chempartner Investment FundTukar CapitalWedo CapitalYD Capital |